Form D Explorer
InSitu Biologics, Inc. · CIK 1723443

Report a data issueCitable research briefCompare issuerPrivate research collection

InSitu Biologics, Inc.

CIK 1723443 · Corporation · Inc. DELAWARE · OAKDALE, Minnesota · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported offering amount was $3,375,000 in the Oct 14, 2026 filing and $19,837,423 in the Nov 10, 2026 filing. The two records may concern different offerings. From Dec 18, 2025 to Nov 10, 2026, the explorer stores 2 original notices and 2 amendments.

Filings
4
Original notices
2
Amendments
2
Activity
Dec 18, 2025
through Nov 10, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldOct 14, 2026 · D/ANov 10, 2026 · D/ALater minus earlier
Reported offering amount$3,375,000$19,837,423$16,462,423
Reported amount sold$1,250,000$15,037,850$13,787,850
Reported investor count12726
Reported minimum investment$2,500,000$1,850$-2,498,150

Earlier SEC source: 0001723443-26-000006 · Later SEC source: 0001723443-26-000008

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Nov 10, 2026

Reported offering amount
$19,837,423
Reported exemptions
Rule 506(b)
Reported amount sold
$15,037,850

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (4)